openPR Logo
Press release

May 12th Deadline in Lawsuit for Investors in shares of Inovio Pharmaceuticals, Inc. (NASDAQ: INO) coming up

04-28-2020 10:26 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Shareholders Foundation

A Deadline is coming up on May 12, 2020 in the lawsuit for certain investors in Inovio Pharmaceuticals, Inc. (NASDAQ: INO).

A Deadline is coming up on May 12, 2020 in the lawsuit for certain investors in Inovio Pharmaceuticals, Inc. (NASDAQ: INO).

The Shareholders Foundation announced that a deadline is coming up on May 12, 2020 in the lawsuit filed for certain investors of Inovio Pharmaceuticals, Inc. (NASDAQ: INO) over alleged securities laws violations by Inovio Pharmaceuticals, Inc.

Investors who purchased shares of Inovio Pharmaceuticals, Inc. (NASDAQ: INO) have certain options and there are strict and short deadlines running. Deadline: May 12, 2020. NASDAQ: INO stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

According to the complaint filed in the U.S. District Court for the Eastern District of Pennsylvania the plaintiff alleges on behalf of purchasers of Inovio Pharmaceuticals, Inc. (NASDAQ: INO) common shares between February 14, 2020 and March 9, 2020, that the defendants violated Federal Securities Laws. More specifically, the plaintiff claims that between February 14, 2020 and March 9, 2020, Inovio made misleading statements about the company's development of a purported vaccine for the novel coronavirus, artificially inflating the company's share price and resulting in significant investor losses.

Those who purchased shares of Inovio Pharmaceuticals, Inc. (NASDAQ: INO) have certain options and should contact the Shareholders Foundation.

Media Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release May 12th Deadline in Lawsuit for Investors in shares of Inovio Pharmaceuticals, Inc. (NASDAQ: INO) coming up here

News-ID: 2028252 • Views: 800

More Releases from Shareholders Foundation

Deadline in Lawsuit for Investors in shares of Velocity Financial, Inc. (NYSE: V …
A deadline is coming up on September 28, 2020 in the lawsuit filed for certain investors of Velocity Financial, Inc. (NYSE: VEL) over alleged securities laws violations by Velocity Financial, Inc. Investors who purchased shares of Velocity Financial, Inc. (NYSE: VEL) have certain options and there are strict and short deadlines running. Deadline: September 28, 2020. NYSE: VEL stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779
Investigation announced for Investors in Lendlease Group (OTC: LLES) over potent …
An investigation on behalf of investors in shares of Lendlease Group (OTC: LLES) was announced over potential breaches of fiduciary duties by certain officers and directors at Lendlease Group . Investors who purchased shares of Lendlease Group (OTC: LLES) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm concerns whether certain Lendlease Group directors breached their fiduciary duties
Lawsuit filed for Investors in shares of Gol Linhas Aéreas Inteligentes S.A. (N …
An investor, who purchased shares of Gol Linhas Aéreas Inteligentes S.A. (NYSE: GOL), filed a lawsuit in the U.S. York over alleged violations of Federal Securities Laws by Gol Linhas Aéreas Inteligentes S.A. Investors who purchased shares of Gol Linhas Aéreas Inteligentes S.A. (NYSE: GOL) have certain options and for certain investors are short and strict deadlines running. Deadline: November 10, 2020. NYSE: GOL investors should contact the Shareholders Foundation at
Investigation announced for Long-Term Investors in shares of Novartis AG (NYSE: …
An investigation on behalf of current long-term investors in shares of Novartis AG (NYSE: NVS) was announced over potential breaches of fiduciary duties by certain directors at Novartis AG. Investors who purchased shares of Novartis AG (NYSE: NVS) and currently hold any of those Novartis AG (NYSE: NVS shares have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm

All 5 Releases


More Releases for Inovio

Needle-Free Drug Delivery Market Competitive Share & Forecast 2019| Endo Pharmac …
Los Angeles, United State, June 4, 2019, - The research study presented here is an intelligent take on the global Needle-Free Drug Delivery Market that explains important aspects such as competition, segmentation, and regional growth in great detail. Accuracy and preciseness are two of the key features of the report that reflect its authenticity. The authors of the report have focused on SWOT analysis, Porter’s Five Forces analysis, and PESTLE analysis
Middle East Respiratory Syndrome (MERS) Therapeutics- Pipeline Analysis 2018, Cl …
Middle East respiratory syndrome (MERS) is a viral respiratory disease caused by a coronavirus (MERS-CoV). Coronaviruses are a type of viruses that affect the respiratory tract of mammals, including humans. Download the sample report @ https://www.pharmaproff.com/request-sample/1066 Human coronaviruses usually cause mild to moderate cold-like illnesses. However, MERS-CoV is different from any other coronavirus previously found in people. The infected patients may have mild symptoms or no symptoms at all, but most people
Cancer Vaccine Market 2019: Competitor Analysis By Dendreon Corporation, NeoStem …
Cancer Vaccine Market research report delivers a close watch on leading competitors with strategic analysis, micro and macro market trend and scenarios, pricing analysis and a holistic overview of the market situations in the forecast period. Get Exclusive FREE Sample Copy Of this Report @ https://www.upmarketresearch.com/home/requested_sample/60990 UpMarketResearch offers a latest published report on “Global Cancer Vaccine Market Analysis and Forecast 2019 - 2025” delivering key insights and providing a competitive advantage
A Comprehensive Study exploring Human DNA Vaccines Market | key players: Inovio …
HTF MI released a new market study on Global Human DNA Vaccines Market with 100+ market data Tables, Pie Chat, Graphs & Figures spread through Pages and easy to understand detailed analysis. At present, the market is developing its presence. The Research report presents a complete assessment of the Market and contains a future trend, current growth factors, attentive opinions, facts, and industry validated market data. The research study provides
Global Zika Virus Vaccines Sales Market Research & Demands 2017 - Inovio Pharmac …
Qyresearchreports include new market research report "Global Zika Virus Vaccines Sales Market Report 2017" to its huge collection of research reports. A thorough overview of the global market for Zika Virus Vaccines has been furnished in this research report. It offers a detailed analysis of the prominent trends prevailing in the market, including important growth drivers and restraints. The report, at the outset, provides a detailed overview of the products and
Global Zika Virus Market 2017 - 2022 Bharat Biotech, Inovio Pharmaceuticals and …
The latest report Zika Virus Market by QY Research added to it's database and brings to light the comprehensive study and factual information of global market. The report also provides the global market segmentation based on applications, end-users, technology, and geography. The Zika Virus research report offers a comprehensive assessment of the Zika Virus market and consists of historical data, scope, significant approaches and statistical data of the global market.